Cargando…
Sera total oxidant/antioxidant status in lung cancer patients
We investigated oxidative stress parameters in the sera of patients with lung cancer and healthy individuals to evaluate their correlations with lung cancer. Ninety-four lung cancer patients and 64 healthy controls were enrolled after obtaining informed consent. Their sera oxidative stress parameter...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6750341/ https://www.ncbi.nlm.nih.gov/pubmed/31517874 http://dx.doi.org/10.1097/MD.0000000000017179 |
_version_ | 1783452444733210624 |
---|---|
author | Xiang, Miao Feng, Jiafu Geng, Lidan Yang, Yuwei Dai, Chunmei Li, Jie Liao, Yao Wang, Dong Du, Xiao-Bo |
author_facet | Xiang, Miao Feng, Jiafu Geng, Lidan Yang, Yuwei Dai, Chunmei Li, Jie Liao, Yao Wang, Dong Du, Xiao-Bo |
author_sort | Xiang, Miao |
collection | PubMed |
description | We investigated oxidative stress parameters in the sera of patients with lung cancer and healthy individuals to evaluate their correlations with lung cancer. Ninety-four lung cancer patients and 64 healthy controls were enrolled after obtaining informed consent. Their sera oxidative stress parameters were measured. Total antioxidant status (TAS), total oxidant status (TOS), and oxidative stress index (OSI) were significantly different between patients and healthy groups (all P < .001). TAS gradually decreased and TOS and OSI gradually increased from stage I to III, but it did not reach statistical significance (all P > .05). TAS and OSI were significantly different between the nonsmoking and smoking groups, radiotherapy and without radiotherapy groups, chemotherapy and without chemotherapy groups (P < .05), but not TOS (P > .05). In a receiver operating characteristic curve analysis comparing patients with lung cancer with healthy controls, the Youden indices of TOS, TAS, and OSI were 0.541, 0.532, and 1, respectively. The oxidative stress may be correlation with lung cancer staging. Smoking, surgery, radiotherapy, and chemotherapy showed correlation with parts oxidative stress parameters. |
format | Online Article Text |
id | pubmed-6750341 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Wolters Kluwer Health |
record_format | MEDLINE/PubMed |
spelling | pubmed-67503412019-10-03 Sera total oxidant/antioxidant status in lung cancer patients Xiang, Miao Feng, Jiafu Geng, Lidan Yang, Yuwei Dai, Chunmei Li, Jie Liao, Yao Wang, Dong Du, Xiao-Bo Medicine (Baltimore) 5700 We investigated oxidative stress parameters in the sera of patients with lung cancer and healthy individuals to evaluate their correlations with lung cancer. Ninety-four lung cancer patients and 64 healthy controls were enrolled after obtaining informed consent. Their sera oxidative stress parameters were measured. Total antioxidant status (TAS), total oxidant status (TOS), and oxidative stress index (OSI) were significantly different between patients and healthy groups (all P < .001). TAS gradually decreased and TOS and OSI gradually increased from stage I to III, but it did not reach statistical significance (all P > .05). TAS and OSI were significantly different between the nonsmoking and smoking groups, radiotherapy and without radiotherapy groups, chemotherapy and without chemotherapy groups (P < .05), but not TOS (P > .05). In a receiver operating characteristic curve analysis comparing patients with lung cancer with healthy controls, the Youden indices of TOS, TAS, and OSI were 0.541, 0.532, and 1, respectively. The oxidative stress may be correlation with lung cancer staging. Smoking, surgery, radiotherapy, and chemotherapy showed correlation with parts oxidative stress parameters. Wolters Kluwer Health 2019-09-13 /pmc/articles/PMC6750341/ /pubmed/31517874 http://dx.doi.org/10.1097/MD.0000000000017179 Text en Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0 |
spellingShingle | 5700 Xiang, Miao Feng, Jiafu Geng, Lidan Yang, Yuwei Dai, Chunmei Li, Jie Liao, Yao Wang, Dong Du, Xiao-Bo Sera total oxidant/antioxidant status in lung cancer patients |
title | Sera total oxidant/antioxidant status in lung cancer patients |
title_full | Sera total oxidant/antioxidant status in lung cancer patients |
title_fullStr | Sera total oxidant/antioxidant status in lung cancer patients |
title_full_unstemmed | Sera total oxidant/antioxidant status in lung cancer patients |
title_short | Sera total oxidant/antioxidant status in lung cancer patients |
title_sort | sera total oxidant/antioxidant status in lung cancer patients |
topic | 5700 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6750341/ https://www.ncbi.nlm.nih.gov/pubmed/31517874 http://dx.doi.org/10.1097/MD.0000000000017179 |
work_keys_str_mv | AT xiangmiao seratotaloxidantantioxidantstatusinlungcancerpatients AT fengjiafu seratotaloxidantantioxidantstatusinlungcancerpatients AT genglidan seratotaloxidantantioxidantstatusinlungcancerpatients AT yangyuwei seratotaloxidantantioxidantstatusinlungcancerpatients AT daichunmei seratotaloxidantantioxidantstatusinlungcancerpatients AT lijie seratotaloxidantantioxidantstatusinlungcancerpatients AT liaoyao seratotaloxidantantioxidantstatusinlungcancerpatients AT wangdong seratotaloxidantantioxidantstatusinlungcancerpatients AT duxiaobo seratotaloxidantantioxidantstatusinlungcancerpatients |